The Microwave Ablation Devices Market is estimated to be valued at USD 499.2 million in 2025 and is projected to reach USD 1883.2 million by 2035, registering a compound annual growth rate (CAGR) of 14.2% over the forecast period.
| Metric | Value |
|---|---|
| Microwave Ablation Devices Market Estimated Value in (2025 E) | USD 499.2 million |
| Microwave Ablation Devices Market Forecast Value in (2035 F) | USD 1883.2 million |
| Forecast CAGR (2025 to 2035) | 14.2% |
The Microwave Ablation Devices market is experiencing steady growth, driven by the increasing adoption of minimally invasive therapies and advancements in imaging-guided ablation technologies. In the current scenario, the market is witnessing higher preference for microwave ablation procedures due to their precision, reduced procedural time, and improved patient outcomes compared to traditional thermal ablation techniques.
Hospitals and specialized oncology centers are increasingly integrating these devices into clinical workflows to treat solid tumors, particularly liver, lung, and kidney malignancies. Factors such as rising cancer incidence, growing awareness of minimally invasive treatment options, and the expansion of healthcare infrastructure in both developed and emerging regions are supporting market growth.
The evolution of generators, probes, and monitoring systems has enhanced procedural accuracy and patient safety, providing clinicians with greater control over energy delivery and treatment planning Looking ahead, the market is expected to benefit from continuous innovations in device miniaturization, software integration, and compatibility with imaging modalities, thereby expanding adoption in both hospital and outpatient settings.
The microwave ablation devices market is segmented by component type, application, end user, and geographic regions. By component type, microwave ablation devices market is divided into Generator, Power Distribution System, and Accessories. In terms of application, microwave ablation devices market is classified into Oncology, Cardiovascular, Urology, Orthopedic, and Others. Based on end user, microwave ablation devices market is segmented into Hospitals, Ambulatory Surgical Centers, and Research Laboratories. Regionally, the microwave ablation devices industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The generator component is projected to hold 47.60% of the Microwave Ablation Devices market revenue share in 2025, establishing it as the leading component type. This prominence is attributed to the generator being the core source of microwave energy, which directly determines ablation efficacy and precision.
Growth in this segment has been supported by technological advancements that allow consistent energy delivery, automated power modulation, and integration with real-time imaging systems. Hospitals and oncology centers prefer generators that are versatile and compatible with multiple probe types, enabling multi-organ treatment without the need for multiple systems.
The high reliability, ease of use, and potential for software-driven performance enhancements have made generators a critical factor in clinical decision-making As minimally invasive treatments continue to gain traction, the generator segment is expected to maintain its leadership due to its central role in ensuring safe, repeatable, and effective ablation procedures.
The oncology application segment is anticipated to capture 58.20% of the market revenue in 2025, making it the dominant application. This leadership has been driven by the rising global incidence of solid tumors and the increasing adoption of minimally invasive treatment approaches in cancer care.
Microwave ablation is particularly favored in oncology for its precision, ability to treat deep-seated tumors, and reduced procedural complications compared to conventional surgery. Hospitals are increasingly implementing ablation therapies as part of multimodal cancer treatment regimens, complementing chemotherapy, radiation, and immunotherapy.
The clinical benefits, including shorter hospital stays, rapid patient recovery, and high local tumor control rates, have accelerated adoption Continued focus on personalized treatment planning and integration with imaging systems is expected to further strengthen the oncology segment, solidifying its position as the primary driver of revenue growth in the Microwave Ablation Devices market.
The hospitals end-user segment is projected to hold 64.50% of the Microwave Ablation Devices market revenue in 2025, making it the largest consumer segment. This leadership is being driven by the concentration of oncology and interventional radiology procedures within hospital settings, where specialized infrastructure and trained personnel are available. Hospitals favor microwave ablation devices due to their versatility, safety profile, and ability to handle complex cases across multiple organs.
Integration with imaging systems and centralized monitoring capabilities allows hospitals to maximize procedural efficiency while ensuring patient safety. Furthermore, hospitals are increasingly adopting minimally invasive procedures to reduce treatment costs, shorten hospital stays, and improve patient outcomes.
Investments in advanced surgical suites, clinical training programs, and software-enabled device management have further strengthened hospital adoption As healthcare providers continue to prioritize precision therapies and minimally invasive interventions, hospitals are expected to remain the dominant end-users, driving sustained growth in the Microwave Ablation Devices market.
Microwave ablation devices are the advance medical devices which are used to treat different type of cancer which can also be treated by radiofrequency (RF) ablation devices. Microwave ablation devices are the ultimate option for minimally invasive surgery of soft tissue such as liver, kidney, and lung. The basic components of microwave devices include a generator, power distribution system and antennas.
Majority of the component of microwave ablation device is the same as the component of RF ablation device. But microwave ablation device has several benefits over the RF ablation devices. Some of the microwave ablation devices are also compatible with the CT scanner and ultrasound scanner, which provide the option for image-guided surgery. The guided surgery with CT scanner or ultrasound scanner enables the surgeon to identify the ablation target more easily though it allows the appropriate probe placement.
This image guide surgery of microwave ablation device has also improved the success rate of the surgery. During the surgery, the needle like antenna is inserted into the tumor. The tip of the antenna emits the electromagnetic radiation, which results the frictional tissue heating and causing the cell death by coagulation necrosis. Majority of the microwave ablation devices available in the market uses 915 MHz generator while few of microwave ablation devices uses 2450 MHz generator.
Increasing incidences of benign and malignant tumor of lung, liver, bone and kidney throughout the globe is the primary factor driving the growth of the microwave ablation devices market. Moreover, the rising number of tumor ablation procedure with the help of image-guided device will also propel the growth of microwave ablation devices market. Additionally, change in the lifestyle of people and unhealthy eating habit along with consumption of alcohol and tobacco is also fueling the number of cancer cases which will ultimately upsurge the growth of microwave ablation devices market.
Increasing demand for minimally invasive procedures and technological advancement is also responsible for the robust growth of microwave ablation devices market throughout the forecast period. The high-cost device associated with high risk during microwave ablation procedure may also impact the sale of microwave ablation devices over the next decade. Also, the high preference of surgeon towards RF ablation device over the microwave ablation device may deter the growth of this market.
Microwave ablation devices market is expected to show significant growth over the forecast period due to rising incidence of cancer throughout the globe. According to the National Cancer Institute, around 1,685,210 new cases of cancer were diagnosed in the USA in 2025. According to the World Health Organization (WHO) data, in 2025, 30-50% of deaths are caused due to cancer can be prevented if the treatment is taken at the early stages.
By component type, accessories segment is expected to dominate the microwave ablation device market by revenue due to rising number of tumor ablation procedure. By application, the oncology segment is expected the gain majority of share for microwave ablation devices market by revenue which is then followed by cardiovascular. Among all end users, the hospital segment is expected to dominate the microwave ablation device market whereas ambulatory surgical centers segment is projected to grow at a faster rate.
Geographically, the global microwave ablation devices market is segmented into North America, Latin America, Europe, CIS and Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to gain maximum market share for microwave ablation devices market in term of revenue owing to increased incidences of cancer.
After North America, microwave ablation devices market is followed by Western Europe and Japan due high health infrastructure in these regions. Asia-Pacific excluding Japan region is expected to grow at a faster rate than other regions for microwave ablation devices market due to rising geriatric population in India and China. Middle East and Africa and Latin America for microwave ablation devices market is expected show delayed growth due to lack of availability of skilled healthcare professionals in this region.
Some of the key players operating in the global Microwave Ablation Devices Market are Medtronic plc, AngioDynamics Inc, Johnson & Johnson Services Inc., MedWaves Inc, and Terumo Corporation.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
| Countries | CAGR |
|---|---|
| China | 19.2% |
| India | 17.8% |
| Germany | 16.3% |
| France | 14.9% |
| UK | 13.5% |
| USA | 12.1% |
| Brazil | 10.7% |
The Microwave Ablation Devices Market is expected to register a CAGR of 14.2% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 19.2%, followed by India at 17.8%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 10.7%, yet still underscores a broadly positive trajectory for the global Microwave Ablation Devices Market.
In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 16.3%. The USA Microwave Ablation Devices Market is estimated to be valued at USD 175.8 million in 2025 and is anticipated to reach a valuation of USD 549.5 million by 2035. Sales are projected to rise at a CAGR of 12.1% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 26.9 million and USD 14.9 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 499.2 Million |
| Component Type | Generator, Power Distribution System, and Accessories |
| Application | Oncology, Cardiovascular, Urology, Orthopedic, and Others |
| End User | Hospitals, Ambulatory Surgical Centers, and Research Laboratories |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | Medtronic, AngioDynamics, Emblation Ltd., HUBER+SUHNER, Johnson & Johnson Services, Inc., MedWaves, Inc., SympleSurgical Inc., Mermaid Medical, Varian Medical Systems, Inc., and Terumo Corporation |
The global microwave ablation devices market is estimated to be valued at USD 499.2 million in 2025.
The market size for the microwave ablation devices market is projected to reach USD 1,883.2 million by 2035.
The microwave ablation devices market is expected to grow at a 14.2% CAGR between 2025 and 2035.
The key product types in microwave ablation devices market are generator, power distribution system and accessories.
In terms of application, oncology segment to command 58.2% share in the microwave ablation devices market in 2025.
Explore Similar Insights
Microwave Ablation Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
